Joseph C. Shanahan
Publications by Year
Research Areas
Systemic Lupus Erythematosus Research, Systemic Sclerosis and Related Diseases, Rheumatoid Arthritis Research and Therapies, Dermatologic Treatments and Research, Autoimmune and Inflammatory Disorders Research
Most-Cited Works
- → Efficacy and safety of rituximab in moderately‐to‐severely active systemic lupus erythematosus: The randomized, double‐blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial(2009)1,365 cited
- → Dialysis‐associated systemic fibrosis (nephrogenic fibrosing dermopathy): Study of inflammatory cells and transforming growth factor β1 expression in affected skin(2004)216 cited
- → The Role of Microparticles in Inflammation and Thrombosis(2007)192 cited
- → MQX‐503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: A randomized, controlled trial(2009)110 cited
- → Tumor Necrosis Factor-α Blockade: A Novel Therapy for Rheumatic Disease(2002)82 cited
- → Upcoming biologic agents for the treatment of rheumatic diseases(2003)55 cited
- → Pulmonary Manifestations of Rheumatoid Diseases(2009)6 cited
- MQX-503, a novel topical nitroglycerin formulation, improves severity of symptoms associated with Raynaud's phenomenon(2008)
- → Inflammatory Diseases of the Coronary Artery(2002)1 cited
- Safety and tolerability of MQX-503, a novel investigational topical formulation of nitroglycerin for the treatment of Raynaud's phenomenon(2008)